Cristian Carlos. Peninsula 360 Press [P360P].
It was reported that, in the state of Florida, a mother, a front-line health care worker, gave birth to a baby girl with antibodies against COVID-19.
The mother, at 36 weeks of pregnancy, reportedly received the Moderna vaccine because she was a frontline health care worker caring for COVID-19 patients.
The delivery took place at the end of January; however, the specialized media MedRxiv reported the research findings recently.
Once the mother gave birth, the researchers took a blood sample from the umbilical cord immediately after it was cut; in addition, plasma was obtained from the placenta to detect whether an antibody test resulted in any reaction to the S protein of the new SARS-CoV-2 coronavirus, which causes the COVID-19 disease estimated to have originated in a market in the Wuhan region of China.
It is important to note that the vaccine from Moderna Pharmaceuticals requires two doses. The mother would have received the second dose during her postpartum period, after 28 days of receiving the first dose of the vaccine to achieve immunity.
The study urges the scientific community to thoroughly investigate the safety and efficacy of vaccines against the new SARS-CoV-2 coronavirus during pregnancy, as the effectiveness in newborns is unknown even when clinical studies show the presence of antibodies against SARS-CoV-2 to prevent disease derived from the new coronavirus: COVID-19.
In addition to their effectiveness in newborns, the researchers also called for research into the ideal time for pregnant women to receive any of the available vaccines.
Details of the research can be accessed through the MedRxiv website: https://www.medrxiv.org/content/10.1101/2021.02.03.21250579v1
